Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Cognetix is a private drug discovery and development company located in Salt Lake City, Utah, focused on commercializing conopeptide-based pharmaceuticals. Conopeptides are bioactive peptides in the venom of marine cone snails. The Company is currently in clinical trials investigating its lead compound, CGX-1160, for the treatment of chronic intractable pain. The Company has a strong drug discovery program in the field of pain, powered by the most extensive conopeptide libraries and conopeptide-related intellectual property position in the world. Cognetix has an exclusive worldwide license to conopeptide-related technology arising from research at the University of Utah and The Salk Institute. It maintains laboratory facilities in both Salt Lake City, Utah and Ivoryton, Connecticut. ( www.cognetix.com )
Cognetix Inc.
421 Wakara Way Suite 201
Salt Lake City, Utah 84108
USA
Tel: (801) 581-0400
Fax: (801) 581-9555